Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin.
Erwan Salaun, Samuel Drory, Marc-André Coté...
https://pubmed.ncbi.nlm.nih.gov/38879450/Actively Recruiting
Led by Technical University of Munich · Updated on 2026-07-24
160
Participants Needed
1
Research Sites
21 weeks
Total Duration
This research aims to evaluate the use of polyethylene glycol precipitation PEG to identify macrotroponin as a cause of persistent troponin elevation. The study focuses on adults with acute coronary syndrome ACS and healthy marathon runners who have undergone cardiological screening and rest. Since macrotroponin formation can lead to false troponin elevations, this study compares PEG results in ACS patients undergoing coronary angiography with marathon runners before and after a race to establish PEG cut-off values. Participants include two groups patients with ACS and healthy marathon runners cleared for competition. PEG testing and transthoracic echocardiography will be performed at presentation and before hospital discharge in ACS patients, while marathon runners will undergo the tests at baseline after 24 hours of rest and within one hour after finishing the marathon. Blood tests for lipids, glucose, and hemoglobin A1c will also be collected at baseline in both groups. During the study, participants will have blood samples analyzed for troponin recovery after PEG precipitation and undergo heart function assessments via echocardiography at specified time points. The main outcome is the PEG recovery of troponin at presentation or baseline, with secondary outcomes including PEG recovery after marathon running or before discharge and left and right ventricular ejection fractions. The study monitors participants until hospital discharge or shortly after marathon completion, providing insight into macrotroponin detection and heart function changes over time.
CONDITIONS
HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin
S
Simon Wernhart, MD, PhD
S
Sebastian Zenk, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Technical University of Munich
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo polyethylene glycol precipitation testing and transthoracic echocardiography at baseline. Blood tests for lipids, glucose, and hemoglobin A1c are also collected. Marathon runners rest for 24 hours before baseline assessment.
1 baseline visit
Duration - 1 day
Patients with acute coronary syndrome have repeat testing before hospital discharge, while marathon runners have follow-up tests within one hour after finishing the race to assess changes.
1 follow-up visit
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Erwan Salaun, Samuel Drory, Marc-André Coté...
https://pubmed.ncbi.nlm.nih.gov/38879450/Robert A Byrne, Xavier Rossello, J J Coughlan...
https://pubmed.ncbi.nlm.nih.gov/37622654/Jesse O Stekelenburg, Kristian Berge, Sylvan L J E Janssen...
https://pubmed.ncbi.nlm.nih.gov/41985028/Ola Hammarsten, Charlotte Becker, Anna E Engberg
https://pubmed.ncbi.nlm.nih.gov/36889375/Ola Hammarsten, Janet V Warner, Leo Lam...
https://pubmed.ncbi.nlm.nih.gov/36952681/Simon Wernhart, Martin Halle, Sebastian Zenk
https://pubmed.ncbi.nlm.nih.gov/42253289/Technical University of Munich
Lead Sponsor